189 related articles for article (PubMed ID: 24157313)
21. Enhancing tumor penetration and targeting using size-minimized and zwitterionic nanomedicines.
Zhang Y; Chen W; Yang C; Fan Q; Wu W; Jiang X
J Control Release; 2016 Sep; 237():115-24. PubMed ID: 27397491
[No Abstract] [Full Text] [Related]
22. Thermal and pH responsive polymer-tethered multifunctional magnetic nanoparticles for targeted delivery of anticancer drug.
Sahoo B; Devi KS; Banerjee R; Maiti TK; Pramanik P; Dhara D
ACS Appl Mater Interfaces; 2013 May; 5(9):3884-93. PubMed ID: 23551195
[TBL] [Abstract][Full Text] [Related]
23. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting.
Kolluru LP; Rizvi SA; D'Souza M; D'Souza MJ
J Drug Target; 2013 Jan; 21(1):77-86. PubMed ID: 23036042
[TBL] [Abstract][Full Text] [Related]
24. Novel micelles from graft polyphosphazenes as potential anti-cancer drug delivery systems: drug encapsulation and in vitro evaluation.
Zheng C; Qiu L; Yao X; Zhu K
Int J Pharm; 2009 May; 373(1-2):133-40. PubMed ID: 19429298
[TBL] [Abstract][Full Text] [Related]
25. pH-responsive biocompatible fluorescent polymer nanoparticles based on phenylboronic acid for intracellular imaging and drug delivery.
Li S; Hu K; Cao W; Sun Y; Sheng W; Li F; Wu Y; Liang XJ
Nanoscale; 2014 Nov; 6(22):13701-9. PubMed ID: 25278283
[TBL] [Abstract][Full Text] [Related]
26. iRGD-coupled responsive fluorescent nanogel for targeted drug delivery.
Su S; Wang H; Liu X; Wu Y; Nie G
Biomaterials; 2013 Apr; 34(13):3523-33. PubMed ID: 23410678
[TBL] [Abstract][Full Text] [Related]
27. Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
Schädlich A; Caysa H; Mueller T; Tenambergen F; Rose C; Göpferich A; Kuntsche J; Mäder K
ACS Nano; 2011 Nov; 5(11):8710-20. PubMed ID: 21970766
[TBL] [Abstract][Full Text] [Related]
28. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
29. Bioreducible heparin-based nanogel drug delivery system.
Wu W; Yao W; Wang X; Xie C; Zhang J; Jiang X
Biomaterials; 2015 Jan; 39():260-8. PubMed ID: 25468376
[TBL] [Abstract][Full Text] [Related]
30. Integrin-targeting thermally cross-linked superparamagnetic iron oxide nanoparticles for combined cancer imaging and drug delivery.
Yu MK; Park J; Jeong YY; Moon WK; Jon S
Nanotechnology; 2010 Oct; 21(41):415102. PubMed ID: 20852354
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
Wong HL; Bendayan R; Rauth AM; Wu XY
J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional phenylboronic acid-tagged fluorescent silica nanoparticles via thiol-ene click reaction for imaging sialic acid expressed on living cells.
Cheng L; Zhang X; Zhang Z; Chen H; Zhang S; Kong J
Talanta; 2013 Oct; 115():823-9. PubMed ID: 24054669
[TBL] [Abstract][Full Text] [Related]
33. The role of non-covalent interactions in anticancer drug loading and kinetic stability of polymeric micelles.
Yang C; Attia AB; Tan JP; Ke X; Gao S; Hedrick JL; Yang YY
Biomaterials; 2012 Apr; 33(10):2971-9. PubMed ID: 22244697
[TBL] [Abstract][Full Text] [Related]
34. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting.
Kaaki K; Hervé-Aubert K; Chiper M; Shkilnyy A; Soucé M; Benoit R; Paillard A; Dubois P; Saboungi ML; Chourpa I
Langmuir; 2012 Jan; 28(2):1496-505. PubMed ID: 22172203
[TBL] [Abstract][Full Text] [Related]
35. A block copolymer of zwitterionic polyphosphoester and polylactic acid for drug delivery.
Sun R; Du XJ; Sun CY; Shen S; Liu Y; Yang XZ; Bao Y; Zhu YH; Wang J
Biomater Sci; 2015 Jul; 3(7):1105-13. PubMed ID: 26221944
[TBL] [Abstract][Full Text] [Related]
36. Supramolecular assembly of cyclodextrin-based nanospheres for gene delivery.
Fan MM; Xi-Zhang ; Li BJ; Sun X; Zhang S
J Control Release; 2011 Nov; 152 Suppl 1():e141-2. PubMed ID: 22195808
[No Abstract] [Full Text] [Related]
37. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-coated BSA nanoparticles lack bone targeting after systemic administration.
Wang G; Kucharski C; Lin X; Uludağ H
J Drug Target; 2010 Sep; 18(8):611-26. PubMed ID: 20158316
[TBL] [Abstract][Full Text] [Related]
39. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation.
Ali ME; Lamprecht A
Int J Pharm; 2013 Nov; 456(1):135-42. PubMed ID: 23958752
[TBL] [Abstract][Full Text] [Related]
40. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Rajan M; Raj V; Al-Arfaj AA; Murugan AM
Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
